Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 4
Submit an article Journal homepage
988
Views
28
CrossRef citations to date
0
Altmetric
Neurology

Clinical and cost implications of amyloid beta detection with amyloid beta positron emission tomography imaging in early Alzheimer’s disease – the case of florbetapir

John HornbergerCedar Associates, Menlo Park, CAUSA; ;Stanford University, Stanford, CAUSA; Correspondence[email protected]
,
Jay BaeEli Lilly and Company, Indianapolis, INUSA;
,
Ian WatsonEli Lilly and Company, Indianapolis, INUSA;
,
Joe JohnstonEli Lilly and Company, Indianapolis, INUSA;
&
Michael HappichEli Lilly and Company, Bad Homburg, Germany
Pages 675-685 | Received 31 May 2016, Accepted 21 Dec 2016, Published online: 24 Jan 2017

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

William Montgomery, Kaname Ueda, Margaret Jorgensen, Shari Stathis, Yuanyuan Cheng & Tomomi Nakamura. (2018) Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan. ClinicoEconomics and Outcomes Research 10, pages 13-28.
Read now

Articles from other publishers (27)

L. Goerdt, F. G. Holz & R. P. Finger. (2023) Retinale optische Kohärenztomographie-Biomarker bei demenziellen ErkrankungenRetinal optical coherence tomography biomarkers in dementia. Die Ophthalmologie 121:2, pages 84-92.
Crossref
Clemens Scott Kruse, Michael E. Mileski, Reagan Wilkinson, Britney Hock, Roger Samson & Taylor Castillo. (2023) Leveraging Technology to Diagnose Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Healthcare 11:23, pages 3013.
Crossref
Sinan Eliaçık, Serdar Aykaç & Hayati Yılmaz. (2023) Optical coherence tomography findings in children of patients with Alzheimer-type dementia. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 59:1.
Crossref
William T. Hu, Ashima Nayyar & Milota Kaluzova. (2023) Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias. Neurotherapeutics 20:4, pages 955-974.
Crossref
Nikita Balaji, Ramya Balachandar, Sarah Algodayan, David M.L. Lilburn, Francesco Fraioli & Jamshed B. Bomanji. (2023) New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer’s disease treatment. Nuclear Medicine Communications 44:6, pages 415-416.
Crossref
Jose Contador, Ana Magdalena Vargas-Martínez, Raquel Sánchez-Valle, Marta Trapero-Bertran & Albert Lladó. (2022) Cost-effectiveness of Alzheimer’s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis. European Archives of Psychiatry and Clinical Neuroscience 273:1, pages 243-252.
Crossref
Carrera‐Muñoz Ismael, Barrios‐López José M, Muñoz‐Martínez Claudia, Romero‐Fábrega Juan C, Vilchez‐Carrillo Rosa M, Del Ser Quijano Teodoro & Carnero‐Pardo Cristoba. (2022) The cognitive performance in the Phototest is predictor of biological markers of Alzheimer's disease. International Journal of Geriatric Psychiatry 37:9.
Crossref
Niamh McCombe, Xuemei Ding, Girijesh Prasad, David P. Finn, Stephen Todd, Paula L. McClean, KongFatt Wong-Lin & Neuroimaging Initiative. (2022) Multiple Cost Optimisation for Alzheimer's Disease Diagnosis. Multiple Cost Optimisation for Alzheimer's Disease Diagnosis.
Rahat Ullah, Tae Ju Park, Xu Huang & Myeong Ok Kim. (2021) Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: Insights and therapeutic approaches from periphery. Ageing Research Reviews 71, pages 101451.
Crossref
Young-Sil Lee, HyunChul Youn, Hyun-Ghang Jeong, Tae-Jin Lee, Ji Won Han, Joon Hyuk Park & Ki Woong Kim. (2021) Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Jacoba A. van de Kreeke, Hoang Ton Nguyen, Elles Konijnenberg, Jori Tomassen, Anouk den Braber, Mara ten Kate, Maqsood Yaqub, Bart van Berckel, Adriaan A. Lammertsma, Dorret I. Boomsma, H. Stevie Tan, Pieter Jelle Visser & Frank D. Verbraak. (2020) Longitudinal retinal layer changes in preclinical Alzheimer’s disease. Acta Ophthalmologica 99:5, pages 538-544.
Crossref
Matteo Cotta Ramusino, Giulia Perini, Daniele Altomare, Paola Barbarino, Wendy Weidner, Gabriella Salvini Porro, Frederik Barkhof, Gil D. Rabinovici, Wiesje M. van der Flier, Giovanni B. Frisoni, Valentina Garibotto, Stefan Teipel & Marina Boccardi. (2021) Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives. European Journal of Nuclear Medicine and Molecular Imaging 48:7, pages 2157-2168.
Crossref
Ismael Carrera-Muñoz, Lucía Triguero-Cueva, Juan C. Romero-Fábrega, Eva M. Triviño-Ibáñez, Rosa Vilchez-Carrillo, Cristóbal Carnero-Pardo & Manuel Gómez-Río. (2020) PET-Amyloid After Inconclusive Cerebrospinal Fluid Biomarkers in Clinical Practice. Is it Necessary to Duplicate Procedures?. Current Alzheimer Research 17:8, pages 698-708.
Crossref
KongFatt Wong-Lin, Paula L. McClean, Niamh McCombe, Daman Kaur, Jose M. Sanchez-Bornot, Paddy Gillespie, Stephen Todd, David P. Finn, Alok Joshi, Joseph Kane & Bernadette McGuinness. (2020) Shaping a data-driven era in dementia care pathway through computational neurology approaches. BMC Medicine 18:1.
Crossref
Paul A. Rowley, Alexey A. Samsonov, Tobey J. Betthauser, Ali Pirasteh, Sterling C. Johnson & Laura B. Eisenmenger. (2020) Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions. Seminars in Ultrasound, CT and MRI 41:6, pages 572-583.
Crossref
Anna HungMonika SchneiderMarianne Hamilton LopezMark McClellan. (2020) Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials. Journal of Managed Care & Specialty Pharmacy 26:7, pages 888-900.
Crossref
Jacoba Alida van de Kreeke, Hoang-Ton Nguyen, Elles Konijnenberg, Jori Tomassen, Anouk den Braber, Mara ten Kate, Maqsood Yaqub, Bart van Berckel, Adriaan A Lammertsma, Dorret I Boomsma, Stevie H Tan, Frank Verbraak & Pieter Jelle Visser. (2020) Optical coherence tomography angiography in preclinical Alzheimer’s disease. British Journal of Ophthalmology 104:2, pages 157-161.
Crossref
Avinash Chandra, Polytimi‐Eleni Valkimadi, Gennaro Pagano, Oliver Cousins, George Dervenoulas & Marios Politis. (2019) Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment. Human Brain Mapping 40:18, pages 5424-5442.
Crossref
Jacoba A. van de Kreeke, Hoang‐Ton Nguyen, Jurre den Haan, Elles Konijnenberg, Jori Tomassen, Anouk den Braber, Mara ten Kate, Lyduine Collij, Maqsood Yaqub, Bart van Berckel, Adriaan A. Lammertsma, Dorret I. Boomsma, Hendra Stevie Tan, Frank D. Verbraak & Pieter Jelle Visser. (2019) Retinal layer thickness in preclinical Alzheimer's disease. Acta Ophthalmologica 97:8, pages 798-804.
Crossref
L. M. Peña-Longobardo, B. Rodríguez-Sánchez, J. Oliva-Moreno, I. Aranda-Reneo & J. López-Bastida. (2019) How relevant are social costs in economic evaluations? The case of Alzheimer’s disease. The European Journal of Health Economics 20:8, pages 1207-1236.
Crossref
Jacopo C. DiFrancesco, Alessandra Pina, Giorgia Giussani, Laura Cortesi, Elisa Bianchi, Luca Cavalieri d’Oro, Emanuele Amodio, Alessandro Nobili, Lucio Tremolizzo, Valeria Isella, Ildebrando Appollonio, Carlo Ferrarese & Ettore Beghi. (2019) Generation and validation of algorithms to identify subjects with dementia using administrative data. Neurological Sciences 40:10, pages 2155-2161.
Crossref
Pei-Jung Lin, Brittany D’Cruz, Ashley A. Leech, Peter J. Neumann, Myrlene Sanon Aigbogun, Dorothee Oberdhan & Tara A. Lavelle. (2019) Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions. PharmacoEconomics 37:4, pages 597-608.
Crossref
Aline Loehfelm, Alisa Boucsein, Dominik Pretz & Alexander Tups. (2019) Timing Matters: Circadian Effects on Energy Homeostasis and Alzheimer’s Disease. Trends in Endocrinology & Metabolism 30:2, pages 132-143.
Crossref
Nelleke Tolboom, Rik Ossenkoppele & Bart N. van Berckel. 2019. PET/CT in Brain Disorders. PET/CT in Brain Disorders 119 129 .
Poul F. Høilund-Carlsen, Jorge R. Barrio, Albert Gjedde, Thomas J. Werner & Abass Alavi. (2018) Circular Inference in Dementia Diagnostics. Journal of Alzheimer's Disease 63:1, pages 69-73.
Crossref
Henryk Barthel & Osama Sabri. (2017) Clinical Use and Utility of Amyloid Imaging. Journal of Nuclear Medicine 58:11, pages 1711-1717.
Crossref
Louise Rice & Sotirios Bisdas. (2017) The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review. European Journal of Radiology 94, pages 16-24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.